Lilly Zovant
Executive Summary
Compassionate use requests for anti-sepsis agent have increased since Lilly announced positive clinical trial results June 19, Critical Care Research Fellow Charles Fischer, MD, said. Lilly will consider modifying conditions for compassionate use as more supplies become available, he added. The manufacturing process is complex, but Lilly had been scaling up to prepare for the potential for a launch based on an interim look at the pivotal trial